Analysis of the List of Drugs Used at Phenikaa University Hospital in 2025

Abstract

Objective: to analyze the structure of the drug formulary used at Phenikaa University Hospital in 2025. Methods: A retrospective cross-sectional descriptive study was conducted on the entire drug formulary used at the hospital from January 1^st, 2025 to December 31, 2025. Data were collected and analyzed using descriptive statistics, ABC, VEN, and ABC/VEN matrix methods. Results: The drug formulary included 1,186 items with a total expenditure of VND 55.8 billion, categorized into 14 pharmacological groups. Anti-infective agents accounted for 19.74%, antineoplastic and immunomodulating agents for 16.88%, and diagnostic radiopharmaceuticals (notably FDG) contributed significantly (17.95% of total expenditure). Imported drugs predominated (66.95% of items; 68.33% of expenditure). Additionally, generic drugs accounted for a high proportion (80.1% of items; 75.86% of expenditure). ABC analysis showed that group A represented 14.59% of items but 79.92% of total expenditure. VEN analysis indicated that essential drugs (E) accounted for 86.77% of total expenditure. By ABC/VEN matrix, the AE group contributed the largest share (71.56% of total expenditure), whereas the CE group comprised the highest number of items (49.58%) but a low expenditure (4.09%). The AN group accounted for a small proportion (1.14% of total expenditure). Conclusion: The drug list is highly concentrated in specialized therapeutic groups, with AE category drugs accounting for the largest expenditure share (71.56%). These findings provide a scientific basis for the hospital to refine its formulary and optimize procurement planning in future operational phases.